Parecoxib is an N-acylsulfonamide resulting from the formal condensation of valdecoxib with propionic acid. It is a prodrug for valdecoxib. Among its listed roles, it functions as a cyclooxygenase 2 inhibitor, a non-narcotic analgesic, a non-steroidal anti-inflammatory drug and a prodrug. It is grouped under the following drug class(es): Cyclooxygenase‑2 (COX‑2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as analgesics, anti-inflammatories and antipyretics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rayzon, parecoxibum and Xapit. Its PubChem CID is 119828.
Parecoxib
| CAS No | 198470-84-7 |
|---|---|
| Molecular Formula | C19H18N2O4S |
| Molecular Weight | 370.4 g/mol |
| Synonyms | N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylpropanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Parecoxib is an N-acylsulfonamide resulting from the formal condensation of valdecoxib with propionic acid. It is a prodrug for valdecoxib. Among its listed roles, it functions as a cyclooxygenase 2 inhibitor, a non-narcotic analgesic, a non-steroidal anti-inflammatory drug and a prodrug.
The listed CAS number is 198470-84-7.
The listed molecular formula is C19H18N2O4S.
The listed molecular weight is 370.4 g/mol.
N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylpropanamide.
The source lists Rayzon, parecoxibum and Xapit.